VEGFA and Retinal pigment epithelial atrophy: This makes it difficult to determine the impact of long-term conbercept treatment on retinal neural function and whether delayed ocular adverse events (such as retinal pigment epithelial atrophy) or potential systemic risks (e.g., the effects of long-term VEGF inhibition on vascular repair) exist [20, 21].